Legal & General Group PLC Intercept Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $16,083 - $30,123	1,610 Added 5.53%	30,739 $569,000
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $114,597 - $241,067	12,497 Added 75.14%	29,129 $322,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $51,172 - $88,663	4,084 Added 32.55%	16,632 $223,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $27,864 - $38,664	2,400 Added 23.65%	12,548 $155,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $8,302 - $13,396	680 Added 7.18%	10,148 $142,000
Q2 2022 Aug 22, 2022	SELL	$11.23 - $19.59 $15,340 - $26,759	-1,366 Reduced 12.61%	9,468 $131,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $4,255 - $5,819	-298 Reduced 2.68%	10,834 $176,000
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $53,986 - $85,073	-4,156 Reduced 27.18%	11,132 $165,000
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $5,240 - $8,305	339 Added 2.27%	15,288 $305,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $657 - $1,283	-34 Reduced 0.23%	14,949 $345,000
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $1,028 - $1,783	-42 Reduced 0.28%	14,983 $370,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $44,132 - $60,333	-1,129 Reduced 6.99%	15,025 $622,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $100,078 - $197,241	2,143 Added 15.3%	16,154 $774,000
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $58,648 - $143,958	-1,213 Reduced 7.97%	14,011 $882,000
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $57,646 - $124,720	1,005 Added 7.07%	15,224 $1.89 Million
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $222,259 - $304,702	3,787 Added 36.3%	14,219 $943,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $72,714 - $112,835	935 Added 9.85%	10,432 $830,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $16,896 - $22,205	184 Added 1.98%	9,497 $1.06 Million
Q4 2018 Feb 15, 2019	BUY	$85.79 - $126.46 $39,806 - $58,677	464 Added 5.24%	9,313 $939,000
Q3 2018 Nov 20, 2018	BUY	$88.49 - $127.55 $184,590 - $266,069	2,086 Added 30.84%	8,849 $1.12 Million
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $145,800 - $208,178	-2,430 Reduced 26.43%	6,763 $567,000
Q1 2018 May 17, 2018	BUY	$52.72 - $67.25 $17,766 - $22,663	337 Added 3.81%	9,193 $565,000
Q4 2017 Feb 13, 2018	BUY	$58.2 - $72.76 $515,419 - $644,362	8,856	8,856 $518,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account